August 5, 2021 Environ, Ag./Food & Bev PAI Top-10

BD Announces Third Fiscal Quarter Results; Strong Base Growth Drives Better Performance In Quarter And Higher Guidance For Fiscal 2021

FRANKLIN LAKES, N.J., Aug. 5, 2021 /PRNewswire/ — Third fiscal quarter revenues of $4.9 billion grew 26.9% on a reported basis. On a currency-neutral basis, revenues increased 22.0%. BD’s COVID-19 testing revenues were $300 million, including BD Veritor™ Plus System revenues of $212 million. Third fiscal quarter GAAP diluted earnings per share (EPS) increased 77.3%... Read more

August 3, 2021 Clinical Research/Diagn. PR/Corporate

Illumina Donates $1 Million in Sequencing Capabilities to Mumbai to Support Sequencing-Based COVID-19 Surveillance in India

Aug 3, 2021 SAN DIEGO, Aug. 3, 2021 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) has donated $1 million in sequencing capabilities to the Molecular Diagnostic Reference Laboratory at Kasturba Hospital, in the Municipal Corporate of Greater Mumbai, to help expand SARS-CoV-2 sequencing capabilities in the region and support the broader genomic surveillance effort across India. Kasturba Hospital was... Read more

August 3, 2021 Life Science Tools PR/Corporate

Agilent Announces Target Enrichment Manufacturing Facility in China

Customers will benefit from reduced delivery time for next generation sequencing (NGS) products  SANTA CLARA, Calif., August 03, 2021  Agilent Technologies Inc. (NYSE: A) today announced that it has established in-country manufacturing for its SureSelect portfolio at its facility in Hangzhou, China. Agilent is a leading provider of next-generation sequencing assays, and customers often develop... Read more

August 3, 2021 Liq. Handling & Robotics

Pacific Biosciences Acquires Circulomics – A Leading High Molecular Weight DNA Extraction Company

MENLO PARK, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or “PacBio”), a leading provider of high-quality, long-read sequencing platforms, announced today that it acquired Circulomics Inc. (“Circulomics”), a Maryland-based biotechnology company focused on delivering highly differentiated sample prep products that enable genomic workflows. Scientists recognize Circulomics... Read more

August 3, 2021 PAI Top-10 PR/Corporate

Xylem Reports Second Quarter 2021 Results

29% organic orders growth on broad underlying demand across segments Revenue growth 16% on a reported basis, 11% organically Adjusted EBITDA margin of 17.3%, up 200 basis points; net income as a percentage of revenue of 8.4%, up 570 basis points Reported net income of $113 million or $0.62 per share; adjusted net income of... Read more

August 3, 2021 Acad, Gov/Utilities

US FDA grants Priority Review to Roche’s Tecentriq as adjuvant treatment for certain people with early non-small cell lung cancer

Basel, 3 August 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) and granted Priority Review for Tecentriq® (atezolizumab) as adjuvant treatment following surgery and platinum-based chemotherapy for people with non-small cell lung cancer (NSCLC) whose tumours... Read more